Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,929 signal articles · 26 in last 24h · 135,794 total before filter · latest 1h ago
26last 24h
1096last 7d
179● bullish (7d)
143● bearish (7d)
209publishers
AllMacro304Earnings357M&A77Regulatory25Product11Analyst15
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Reuters13d agoneutral
Hugging Face exploring sale valuing it at $13 billion, Business Insider says

AI startup Hugging Face has been exploring a sale that could ‌value the company at $13 billion or ‌more, Business Insider reported on Sunday, citing people familiar with ​the matter. The New York-based company, which hosts open-source large language models and datasets, has been working with a bank to gauge bidders' interest, the ‌report said. • Hugging Face did not immediately respond to a Reuters ⁠request for comment outside regular business hours.

Investing.com13d agoneutral
Citi expects Nvidia stock to trade higher post earnings

Investing.com -- Nvidia is expected to report stronger-than-anticipated quarterly sales next week, with Citi raising its revenue forecasts on improved shipments of AI networking components and a continued ramp-up of the company's Blackwell chips.

Hype for Moderna’s Cancer Vaccine Is Running Ahead of the Math
The Wall Street Journal13d agoneutral
Hype for Moderna’s Cancer Vaccine Is Running Ahead of the Math

Moderna has always been a stock driven by narrative extremes. During the pandemic, it traded as if mRNA would transform medicine overnight, with its market capitalization peaking near $200 billion. Shares exploded 177% in a single session on Wednesday—the largest one-day surge for an S&P 500 company in over two decades—after Moderna and partner Merck reported successful late-stage trial results for their personalized mRNA melanoma vaccine.